These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35436499)

  • 41. Efficacy of mouthrinses in reducing oral SARS-COV-2 load: a review.
    Pannuti CM; Reis INRD; Souza NV; Souto MLS; Silva CGB; Bezinelli LM; Machado CM; Romito GA; Villar CC
    Braz Oral Res; 2023; 37():e038. PubMed ID: 37132726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Virucidal Activity of Over-the-Counter Oral Care Products Against SARS-CoV-2.
    Ramji N; Circello B; Winston JL; Biesbrock AR
    Oral Health Prev Dent; 2022 Apr; 20():185-192. PubMed ID: 35481342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2.
    Okamoto N; Saito A; Okabayashi T; Komine A
    J Oral Maxillofac Surg Med Pathol; 2022 Nov; 34(6):800-804. PubMed ID: 35441076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of mouth rinses with povidone-iodine and hydrogen peroxide in patients with COVID-19.
    Pablo-Marcos D; Abascal B; Lloret L; Gutiérrez Cuadra M; Velasco N; Valero C
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Mar; 41(3):173-175. PubMed ID: 36058840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of antiseptics in the prevention and treatment of infections in nursing homes.
    Alves PJ; Gryson L; Hajjar J; Lepelletier D; Reners M; Rodríguez Salazar J; Simon A
    J Hosp Infect; 2023 Jan; 131():58-69. PubMed ID: 36216172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of antiseptic mouth rinses on SARS-CoV-2 infectivity in vitro.
    Xu C; Wang A; Hoskin ER; Cugini C; Markowitz K; Chang TL; Fine DH
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of povidone-iodine and chlorhexidine mouth rinses on plaque Streptococcus mutans count in 6- to 12-year-old school children: an in vivo study.
    Neeraja R; Anantharaj A; Praveen P; Karthik V; Vinitha M
    J Indian Soc Pedod Prev Dent; 2008 Jan; 26 Suppl 1():S14-8. PubMed ID: 18974539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro.
    Rius-Salvador M; García-Múrria MJ; Rusu L; Bañó-Polo M; León R; Geller R; Mingarro I; Martinez-Gil L
    PLoS One; 2024; 19(2):e0297291. PubMed ID: 38363760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preprocedural mouthwashes for infection control in dentistry-an update.
    Weber J; Bonn EL; Auer DL; Kirschneck C; Buchalla W; Scholz KJ; Cieplik F
    Clin Oral Investig; 2023 Jun; 27(Suppl 1):33-44. PubMed ID: 37079156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virucidal Activity of Different Mouthwashes Using a Novel Biochemical Assay.
    Rodríguez-Casanovas HJ; la Rosa M; Bello-Lemus Y; Rasperini G; Acosta-Hoyos AJ
    Healthcare (Basel); 2021 Dec; 10(1):. PubMed ID: 35052227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dental Practitioners' Knowledge, Attitude and Practices for Mouthwash Use Amidst the COVID-19 Pandemic.
    Imran E; Khurshid Z; Adanir N; Ashi H; Almarzouki N; Baeshen HA
    Risk Manag Healthc Policy; 2021; 14():605-618. PubMed ID: 33623451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial.
    Sevinç Gül SN; Dilsiz A; Sağlık İ; Aydın NN
    Dent Med Probl; 2022; 59(3):357-363. PubMed ID: 35904769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study.
    Grover V; Kumar V; Puri V; Jain A
    J Indian Soc Periodontol; 2022; 26(5):512-514. PubMed ID: 36339382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virucidal effect of povidone-iodine against SARS-CoV-2
    Wang Y; Wu Y; Wang Q; Zhu J; Shi W; Han Z; Zhang Y; Chen K
    J Int Med Res; 2021 Dec; 49(12):3000605211063695. PubMed ID: 34914884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preprocedural Viral Load Effects of Oral Antiseptics on SARS-CoV-2 in Patients with COVID-19: A Systematic Review.
    Ting M; Dahlkemper A; Schwartz JJ; Woodfork M; Suzuki JB
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
    Frank S; Capriotti J; Brown SM; Tessema B
    Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Khan FR; Kazmi SMR; Iqbal NT; Iqbal J; Ali ST; Abbas SA
    Trials; 2020 Sep; 21(1):785. PubMed ID: 32928313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is the oral cavity relevant in SARS-CoV-2 pandemic?
    Herrera D; Serrano J; Roldán S; Sanz M
    Clin Oral Investig; 2020 Aug; 24(8):2925-2930. PubMed ID: 32577830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro virucidal activity of mouthwashes on SARS-CoV-2.
    Buonavoglia A; Lanave G; Marchi S; Lorusso P; Montomoli E; Martella V; Camero M; Prati C; Trombetta CM
    Oral Dis; 2022 Nov; 28 Suppl 2():2509-2515. PubMed ID: 35398970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.